0
Cardiff Oncology, Inc. Banner Image

Cardiff Oncology, Inc.

  • Ticker CRDF
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cardiff Oncology, Inc. Logo Image
  • 11-50 Employees
  • Based in San Diego, California
Cardiff Oncology is a clinical-stage biotechnology company, headquartered in San Diego, CA, leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers. Their lead asset is onvansertib, a PLK1 inhibitor being evaluated in combination with standard-of-care (SoC) therapeutics in clinical programs targeting indications such as KRAS/NRAS-mutatedMore metastatic colorectal cancer (mCRC) and metastatic pancreatic ductal adenocarcinoma (mPDAC), as well as in investigator-initiated trials in triple negative breast cancer (TNBC) and small cell lung cancer (SCLC).
Cardiff Oncology, Inc.

Most Recent Annual Report

Cardiff Oncology, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Cardiff Oncology, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!